Company Filing History:
Years Active: 2009
Title: Innovator Mathias Frech: Pioneering Glycoprotein VI Fusion Proteins
Introduction: Mathias Frech, an accomplished inventor based in Darmstadt, Germany, has made significant contributions to the field of biochemistry with his patented invention of Glycoprotein VI (GPVI) fusion proteins. This innovative work is set to enhance the understanding and treatment of thrombotic and cardiovascular disorders.
Latest Patents: Mathias Frech holds a notable patent for Glycoprotein VI fusion proteins, which include a variety of tags such as myc, GST, HA, FLAG, and STREP. However, the preferred embodiment involves an immunoglobulin molecule, notably a Fc portion, alongside a protein or oligopeptide that exhibits the biological activity of GPVI. This invention is designed to facilitate the screening of potential agonists or antagonists for GPVI-collagen and/or platelet-collagen interactions, showing promise for therapeutic compositions and methods aimed at addressing thrombotic and cardiovascular events.
Career Highlights: Mathias is associated with Merck Patent GmbH, a renowned company in the pharmaceutical industry. His work at Merck is characterized by a strong focus on innovative therapeutic solutions, utilizing his expertise to advance product development in line with clinical needs.
Collaborations: Throughout his career, Mathias has collaborated closely with talented colleagues such as Christa Burger and Johannes Gleitz. Their collective efforts have contributed to significant advancements in research and development related to the interaction of GPVI with collagen, further strengthening the impact of their work in the medical field.
Conclusion: As an inventor, Mathias Frech exemplifies dedication and innovation in his field. His patented work on Glycoprotein VI fusion proteins holds considerable potential for advancing therapeutic options in the treatment of thrombotic and cardiovascular disorders. The collaborative environment at Merck Patent GmbH, paired with his expertise and novel ideas, positions him as a key player in transforming how these conditions are approached and managed.